In yesterday’s Wall Street session, Xenon Pharmaceuticals Inc (NASDAQ:XENE) shares traded at $43.15, up 1.65% from the previous session.
XENE stock price is now 4.31% away from the 50-day moving average and 4.26% away from the 200-day moving average. The market capitalization of the company currently stands at $3.29B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On October 01, 2024, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $53, while ‘Citigroup’ rates the stock as ‘Buy’
In other news, PATOU GARY, Director sold 4,891 shares of the company’s stock on Nov 22 ’24. The stock was sold for $200,947 at an average price of $41.08. Upon completion of the transaction, the Director now directly owns 23,573 shares in the company, valued at $1.02 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 22 ’24, Director GARY PATOU bought 4,891 shares of the business’s stock. A total of $200,932 was incurred on buying the stock at an average price of $41.08. A total of 3.88% of the company’s stock is owned by insiders.
During the past 12 months, Xenon Pharmaceuticals Inc has had a low of $29.00 and a high of $50.99. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 22.21, and a quick ratio of 22.21. The fifty day moving average price for XENE is $41.3072 and a two-hundred day moving average price translates $41.4116 for the stock.
The latest earnings results from Xenon Pharmaceuticals Inc (NASDAQ: XENE) was released for 2024-06-30. The company reported revenue of $73.68 million for the quarter, compared to $55.68 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 32.31 percent.
